Advancing Technologies for Spatiotemporal Omics in Live Tissue Grant

Advancing Technologies for Spatiotemporal Omics in Live Tissue Grant

Status: ACTIVE
Funder: Chan Zuckerberg Initiative Foundation
Amount: US $250,000 - US $500,000
Last Updated: September 18, 2025

Summary

The Chan Zuckerberg Initiative is calling for transformative research proposals through the Advancing Technologies for Spatiotemporal Omics in Live Tissue program. This initiative seeks to combine innovative engineering with biological research to explore the complex molecular dynamics of health and disease. By fostering collaboration among scientists and AI experts, this funding aims to unlock new high-precision interventions, significantly advancing our understanding and management of health issues.

Overview

Chan Zuckerberg Initiative The Chan Zuckerberg Initiative supports the science and technology to make it possible to cure, prevent and manage all disease in this century. Founded in 2015, CZI helps solve some of society's toughest challenges. Our Science Focus We bring scientists, engineers, and AI and machine learning experts together to tackle complex scientific grand challenges. Advancing Technologies for Spatiotemporal Omics in Live Tissue Chan Zuckerberg Biohub Network and the Chan Zuckerberg Initiative invite applications for two-year initial research projects that merge cutting-edge engineering with deep biological inquiry to illuminate the dynamic molecular landscape of health and disease, unlocking new frontiers in high-precision interventions. This RFA represents a strategic investment in transformative research with the potential to drive breakthroughs that significantly advance our health.

Eligibility

We've imported the main document for this grant to give you an overview. You can learn more about this opportunity by visiting the funder's website.